VetOncoRx is a biopharmaceutical company that focuses on the treatment of canine cancers, including hemangiosarcoma, melanoma and osteosarcoma. VetOncoRx is taking preclinical drugs for humans and adapting them to treat the corresponding affliction in dogs. VetOncoRx is working side by side with the Animal & Veterinary branch of the FDA for preclinical development and, ultimately, clinical approval of first-in-class molecular targeted cancer therapeutics in dogs. Our drug candidates target a translation initiation factor that is responsible for uncontrolled growth in a multitude of mammalian cancers. These innovative drugs for dogs are designed to block cancer growth and inhibit disease progression while producing fewer side effects. VetOncoRx will revolutionize canine treatment options where there is currently a huge void in available therapeutics.
View Top Employees from Egenix INCWebsite | http://www.vetoncorx.com |
Revenue | $6 million |
Employees | 7 (0 on RocketReach) |
Founded | 1991 |
Address | PO Box 1107, Millbrook, New York 12545, US |
Phone | (845) 677-5317 |
Fax | (845) 677-3482 |
Industry | Manufacturing General, Biotechnology, Manufacturing |
Competitors | CellCentric, Forge Therapeutics, Inc., Second Genome Inc., Vivoryon Therapeutics N.V., ZEDIRA GmbH |
SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Egenix INC employee's phone or email?
The Egenix INC annual revenue was $6 million in 2023.
Egenix INC is based in Millbrook, New York.
The NAICS codes for Egenix INC are [32, 3254, 325].
The SIC codes for Egenix INC are [28, 283, 80].